In Situ Hydrogel Global Market Report 2025: Market Opportunities & Challenges Outlook

The global market for In Situ Hydrogel was estimated to be worth US$ 23.8 million in 2024 and is forecast to a readjusted size of US$ 35.1 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031. In situ hydrogel, also known as instant gel, is a type of preparation that undergoes phase transition at the site of administration after being administered in a solution state, solidifying from liquid to form a semi-solid gel. To date, a total of 8 in situ hydrogel injections have been approved worldwide, including analgesics, psychiatric drugs, local anesthetics, etc. These drugs have an irreplaceable position in the treatment of diseases, but have the disadvantages of a short half-life, require frequent injections, and have extremely poor patient compliance, especially when used for diseases such as mental illness and pain.